The Global Burden of Alcohol-associated Cirrhosis and Cancer in Young and Middle-aged Adults
- PMID: 38428708
- PMCID: PMC11344661
- DOI: 10.1016/j.cgh.2024.02.011
The Global Burden of Alcohol-associated Cirrhosis and Cancer in Young and Middle-aged Adults
Abstract
Alcohol is a substance that impacts premature mortality and morbidity.1 The liver is invariably subjected to the impact of alcohol, which can result in cirrhosis and cancer. Alcohol also has detrimental effects that extend beyond the liver. While traditionally associated with advanced age, emerging data reported a rising burden of cancers and alcohol-associated liver disease in the young.1-3 Thus, the primary objective was to evaluate the trend of alcohol-associated cirrhosis and cancer in young and middle-aged adults (aged 15-49) utilizing the Global Burden of Disease Study (GBD) 2019.4 We chose the age group less than 50 years old based on the definition of early-onset cancer and the inherent selection of the age group in the GBD database.4-6 The detailed methods are provided in the Supplementary Appendix. Briefly, data were sourced from population-based cancer registries, vital registration systems, or verbal autopsy studies. Verbal autopsy is a well-established approach for monitoring health, providing valuable information on mortality patterns and the reasons behind deaths in areas lacking robust medical death certification processes. The researchers employed the Cause of Death Ensemble model to estimate the burden linked to cancer and cirrhosis associated with alcohol use.
Copyright © 2024 AGA Institute. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Conflict of interest
These authors disclose the following: Cheng Han Ng has served as a consultant for Boxer Capital. Hirokazu Takahashi has received research grants from Astellas Pharma, AbbVie GK, and Sysmex. Daniel Q. Huang has served as an advisory board member for Eisai and receives funding support from the Singapore Ministry of Health’s National Medical Research Council under its NMRC Research Training Fellowship (MOH-000595–01). Mazen Noureddin has been on the advisory board for 89BIO, Gilead, Intercept, Pfizer, Novo Nordisk, Blade, EchoSens, Fractyl, Terns, Siemens, and Roche Diagnostic; has received research support from Allergan, BMS, Gilead, Galmed, Galectin, Genfit, Conatus, Enanta, Madrigal, Novartis, Pfizer, Shire, Viking, and Zydus; and is a minor shareholder or has stocks in Anaetos, Rivus Pharma, and Viking. Vincent Chen’s institution has received research grants from KOWA and AstraZeneca. The remaining author discloses no conflicts.
Figures

Similar articles
-
The global, regional, and national burden of oesophageal cancer and its attributable risk factors in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.Lancet Gastroenterol Hepatol. 2020 Jun;5(6):582-597. doi: 10.1016/S2468-1253(20)30007-8. Epub 2020 Apr 1. Lancet Gastroenterol Hepatol. 2020. PMID: 32246941 Free PMC article.
-
Global, regional, and national burden of cirrhosis and other chronic liver diseases due to alcohol use, 1990-2019: a systematic analysis for the Global Burden of Disease study 2019.BMC Gastroenterol. 2022 Nov 23;22(1):484. doi: 10.1186/s12876-022-02518-0. BMC Gastroenterol. 2022. PMID: 36418998 Free PMC article.
-
[Analysis and prediction of disease burden of cirrhosis and other chronic liver diseases due to alcohol use in China from 1990 to 2030].Zhonghua Liu Xing Bing Xue Za Zhi. 2024 Feb 10;45(2):185-191. doi: 10.3760/cma.j.cn112338-20230920-00173. Zhonghua Liu Xing Bing Xue Za Zhi. 2024. PMID: 38413055 Chinese.
-
Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.Lancet Psychiatry. 2022 Feb;9(2):137-150. doi: 10.1016/S2215-0366(21)00395-3. Epub 2022 Jan 10. Lancet Psychiatry. 2022. PMID: 35026139 Free PMC article.
-
Global burden of alcoholic liver diseases.J Hepatol. 2013 Jul;59(1):160-8. doi: 10.1016/j.jhep.2013.03.007. Epub 2013 Mar 16. J Hepatol. 2013. PMID: 23511777 Review.
Cited by
-
Temporal trends in disability adjusted life year and mortality for colorectal cancer attributable to a high red meat diet in China from 1990 to 2021: an analysis of the global burden of disease study 2021.BMC Gastroenterol. 2024 Dec 27;24(1):476. doi: 10.1186/s12876-024-03563-7. BMC Gastroenterol. 2024. PMID: 39731045 Free PMC article.
-
Alcohol-Associated Liver Disease Mortality.JAMA Netw Open. 2025 Jun 2;8(6):e2514857. doi: 10.1001/jamanetworkopen.2025.14857. JAMA Netw Open. 2025. PMID: 40498484 Free PMC article.
-
Changes in the epidemiological trends of primary liver cancer in the Asia-Pacific region.Sci Rep. 2024 Aug 22;14(1):19544. doi: 10.1038/s41598-024-70526-z. Sci Rep. 2024. PMID: 39174722 Free PMC article.
-
Comparative study of early onset cancer burden between China and the United States from 1990 to 2021.Sci Rep. 2025 Aug 5;15(1):28527. doi: 10.1038/s41598-025-10185-w. Sci Rep. 2025. PMID: 40764701 Free PMC article.
-
Disparity in trends and characteristics of early onset colorectal cancer: analysis from the National Inpatient Sample, 2016 to 2021.Proc (Bayl Univ Med Cent). 2024 Sep 19;37(6):928-933. doi: 10.1080/08998280.2024.2401757. eCollection 2024. Proc (Bayl Univ Med Cent). 2024. PMID: 39440091 Free PMC article.
References
-
- Danpanichkul P, et al. Am J Gastroenterol 2023.
-
- Danpanichkul P, et al. J Gastroenterol Hepatol 2023;38:2053–2060. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources